Artiva Targets $116M in Latest IPO Push 0 15.07.2024 03:00 Feedity.com Cell therapy biotech Artiva Biotherapeutics plans to use the funds raised to support the development of its AlloNK therapy for systemic lupus erythematosus. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
